American Family Pharmacy, LLC
FDA inspection history in Indianapolis, Indiana, 2014
- 2
- Form 483s
Every document, by year
- Form 483
2014: one amended 483 and one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2014One amended 483 and one Form 483, at Indianapolis, Indiana.
- 2014The longest 483 on file: 13 observations over 12 pages at Indianapolis, Indiana.
Cited most
Across all American Family Pharmacy observations on file
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products2
- 21 CFR 211.130Packaging and labeling operations2
- 21 CFR 211.142(b)Warehousing procedures2
- 21 CFR 211.160(b)(1)General requirements2
- 21 CFR 211.165(a)Testing and release for distribution2
The complete American Family Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Indianapolis, Indiana
One amended 483 and one Form 483 · 2014 · 26 observations
Latest: Form 483, Jul 21, 2014 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2014-07-21 | Amended 483 Amended 483 | Indianapolis, Indiana | 13 | $99 |
| 2014-07-08 | 483 Form 483 | Indianapolis, Indiana | 13 | $99 |
Investigators on these documents
FEI number 3004971302 · most recent document Jul 21, 2014
About American Family Pharmacy, LLC
How many FDA Form 483s has American Family Pharmacy, LLC received?
FDA Intel has 2 Form 483s on file for American Family Pharmacy, LLC; the most recent is dated Jul 21, 2014.
When was American Family Pharmacy, LLC last inspected by FDA?
The most recent FDA inspection document on file for American Family Pharmacy, LLC is a Form 483 dated Jul 21, 2014, for the site in Indianapolis, Indiana.
What did FDA cite at American Family Pharmacy, LLC?
The regulations cited most in the observations on file for American Family Pharmacy, LLC are 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.130 (Packaging and labeling operations), 2 times; 21 CFR 211.142(b) (Warehousing procedures), 2 times.